Pharmacists are the medication experts on America’s health care team. The APhA Media Advisors and staff pharmacists can help the media make sense of pharmacist clinical services, over-the-counter products, prescription medications, vitamin and herbal supplements, as well as many other topics. These pharmacists are ready to help develop stories about medication use and how the pharmacist helps improve patient health and reduce health care costs.
Contact: Frank Fortin at firstname.lastname@example.org or at 202-223-7189.
March 29, 2021
White House’s expansion of pharmacy vax program brings COVID-19 goals closer to reality
The American Pharmacists Association (APhA) today cheered the White House’s move to fully activate the pharmacies in the Federal Retail Pharmacy Program, which is a piece of the national COVID-19 vaccination strategy.
March 29, 2021
American Pharmacists Association Collaborates with CDC to Build the Public’s Confidence in COVID-19 Vaccines
The American Pharmacists Association (APhA) announced today that it has entered into a collaborative agreement with the Centers for Disease Control and Prevention (CDC) to support the CDC’s efforts to build the American public’s confidence in the COVID-19 vaccines.
March 19, 2021
Guest blog: After Atlanta, an entire community is feeling…
We join all Americans in mourning the victims of this week’s horrific shootings in Atlanta. We don’t need authorities to formally declare a motive to know in our hearts that these were clearly hate…0 comments
News View all news
FDA approves first cell-based gene therapy for adult patients with multiple myeloma
FDA has approved idecabtagene vicleuce (Abecma—Celgene), a cell-based gene therapy to treat adult patients with multiple myeloma who have not responded to, or whose disease has returned after, at least four prior lines (different types) of therapy. It is the first cell-based gene therapy approved by FDA for the treatment of multiple myeloma.
Pandemic seems to have affected telehealth use disproportionately
Telehealth has been a welcomed service for both patients and health care providers during the COVID-19 pandemic, but a new study published in the American Journal of Preventive Medicine found that these services were mostly accessed by those living in affluent and metropolitan areas.
FDA authorizes first AI-powered armband for COVID-19 screening
FDA granted an emergency use authorization (EUA) for the first machine learning–based COVID-19 nondiagnostic screening device. The Tiger Tech COVID Plus Monitor identifies certain biomarkers that may be indicative of SARS-CoV-2 infection. It can also detect hypercoagulable conditions, such as sepsis or cancer, or hyper-inflammatory states in asymptomatic individuals over the age of 5 years.